Načítá se...
SUN-587 Oral Liothyronine (LT3) May Be Better Absorbed Compared to LT4 Tablets after Biliopancreatic Diversion Surgery
Introduction: Levothyroxine (LT4) is the mainstay of treating hypothyroidism patients. Increased levothyroxine requirements are expected after bariatric surgery and small bowel diseases. There have been studies showing treatment of resistant hypothyroidism following bariatric surgery with soft gel o...
Uloženo v:
| Vydáno v: | J Endocr Soc |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Endocrine Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553176/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-587 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|